Last updated: 3 months ago
AstraZeneca's Imfinzi Breakthrough: POTOMAC Trial Insights on Bladder Cancer Treatment
Discover key findings from AstraZeneca's 6-K filing on Imfinzi, highlighting significant advancements in treating high-risk non-muscle-invasive bladder cancer through the POTOMAC trial.